CD274 and cancer: In addition to common PD-L1 expression, CSCs from some cancer types were shown to express Galectin-3, a ligand of LAG3, Galectin-9, a ligand of TIM-3, and even the expression of CTLA-4 and TIM-3 receptors indicating a close relationship between CSCs and immune checkpoint molecules [20–22].